Epstein-Barr virus colonization of tonsillar and peripheral blood B-cell subsets in primary infection and persistence

Blood

Volumn 113, Issue 25, 2009, Pages 6372-6381

  Chaganti, Sridhar ^a   Heath, Emily M ^a   Bergler, Wolfgang ^b   Kuo, Michael ^c   Buettner, Maike ^d   Niedobitek, Gerald ^e   Rickinson, Alan B ^a   Bell, Andrew I ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b Krankenhaus St Joseph Stift Bremen   (Germany)

^c BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^e UNFALLKRANKENHAUS BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CD38 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; GLOBOTRIAOSYLCERAMIDE; IMMUNOGLOBULIN D; CD38 PROTEIN, HUMAN; MEMBRANE PROTEIN;

ADULT; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; INFECTIOUS MONONUCLEOSIS; MEMORY CELL; PERSISTENT VIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIMARY INFECTION; PRIORITY JOURNAL; TONSIL CELL; VIRUS CARRIER; VIRUS LOAD; BIOLOGICAL MODEL; BLOOD CELL; CYTOLOGY; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; PALATINE TONSIL; PATHOLOGY; PHYSIOLOGY; VIRAL PHENOMENA AND FUNCTIONS; VIROLOGY; VIRUS INFECTION;

ADULT; ANTIGENS, CD38; B-LYMPHOCYTE SUBSETS; BLOOD CELLS; EPSTEIN-BARR VIRUS INFECTIONS; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOLOGIC MEMORY; MEMBRANE GLYCOPROTEINS; MODELS, IMMUNOLOGICAL; PALATINE TONSIL; VIRAL LOAD; VIRUS PHYSIOLOGICAL PROCESSES;

EID: 67650601926     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-08-175828     Document Type: Article

References (50)

1. Rickinson AB, Kieff E. Epstein-Barr virus. In: Knipe DM, Howley PM, eds. Fields Virology. Vol.2 (ed 5). Philadelphia, PA: Lippincott Williams & Wilkins; 2006:2655-2700.
2. Anagnostopoulos I, Hummel M, Kreschel C, Stein H. Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood. 1995;85:744-750.
3. Niedobitek G, Agathanggelou A, Herbst H, Whitehead L, Wright DH, Young LS. Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells. J Pathol. 1997;182:151-159. (Pubitemid 27287835)
4. Kurth J, Spieker T, Wustrow J, et al. EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency. Immunity. 2000;13:485-495. (Pubitemid 30951872)
5. Miyashita EM, Yang B, Babcock GJ, Thorley-Lawson DA. Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell. J Virol. 1997;71:4882-4891. (Pubitemid 27258155)
6. Babcock GJ, Decker LL, Freeman RB, Thorley-Lawson DA. Epstein-Barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients. J Exp Med. 1999;190: 567-576.
7. Laichalk LL, Hochberg D, Babcock GJ, Freeman RB, Thorley-Lawson DA. The dispersal of mucosal memory B cells: evidence from persistent EBV infection. Immunity. 2002;16:745-754. (Pubitemid 34626694)
8. Klein U, Rajewsky K, Kuppers R. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med. 1998;188: 1679-1689. (Pubitemid 28516113)
9. Weller S, Faili A, Garcia C, et al. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. Proc Natl Acad Sci U S A. 2001;98:1166-1170. (Pubitemid 32121204)
10. Weller S, Reynaud CA, Weill JC. Splenic marginal zone B cells in humans: where do they mutate their Ig receptor? Eur J Immunol. 2005;35: 2789-2792.
11. Tangye SG, Good KL. Human IgM+CD27+ B cells: memory B cells or "memory" B cells? J Immunol. 2007;179:13-19.
12. Agematsu K, Nagumo H, Shinozaki K, et al. Absence of IgD-CD27(+) memory B cell population in X-linked hyper-IgM syndrome. J Clin Invest. 1998;102:853-860. (Pubitemid 28399619)
13. Hochberg D, Souza T, Catalina M, Sullivan JL, Luzuriaga K, Thorley-Lawson DA. Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells. J Virol. 2004;78: 5194-5204. (Pubitemid 38581471)
14. Babcock GJ, Decker LL, Volk M, Thorley-Lawson DA. EBV persistence in memory B cells in vivo. Immunity. 1998;9:395-404. (Pubitemid 28462760)
15. Joseph AM, Babcock GJ, Thorley-Lawson DA. EBV persistence involves strict selection of latently infected B cells. J Immunol. 2000;165: 2975-2981.
16. Ehlin-Henriksson B, Gordon J, Klein G. B-lymphocyte subpopulations are equally susceptible to Epstein-Barr virus infection, irrespective of immunoglobulin isotype expression. Immunology. 2003;108:427-430. (Pubitemid 36469679)
17. Babcock GJ, Hochberg D, Thorley-Lawson AD. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity. 2000;13:497-506. (Pubitemid 30951873)
18. Joseph AM, Babcock GJ, Thorley-Lawson DA. Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils. J Virol. 2000;74: 9964-9971.
19. Thorley-Lawson DA. Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol. 2001; 1:75-82.
20. Kuppers R. B cells under influence: transformation of B cells by Epstein-Barr virus. Nat Rev Immunol. 2003;3:801-812. (Pubitemid 37328658)
21. Kurth J, Hansmann ML, Rajewsky K, Kuppers R. Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction. Proc Natl Acad Sci U S A. 2003;100: 4730-4735. (Pubitemid 36457798)
22. Hislop AD, Kuo M, Drake-Lee AB, et al. Tonsillar homing of Epstein-Barr virus-specific CD8+ T cells and the virus-host balance. J Clin Invest. 2005;115:2546-2555. (Pubitemid 41266217)
23. Pascual V, Liu YJ, Magalski A, de Bouteiller O, Banchereau J, Capra JD. Analysis of somatic mutation in five B-cell subsets of human tonsil. J Exp Med. 1994;180:329-339. (Pubitemid 24181081)
24. Junying J, Herrmann K, Davies G, et al. Absence of Epstein-Barr virus DNA in the tumor cells of European hepatocellular carcinoma. Virology. 2003;306:236-243. (Pubitemid 36299272)
25. Bell AI, Groves K, Kelly GL, et al. Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative realtime PCR assays. J Gen Virol. 2006;87:2885-2890. (Pubitemid 44463896)
26. Chaganti S, Ma CS, Bell AI, et al. Epstein-Barr virus persistence in the absence of conventional memory B cells: IgM+IgD+CD27+ B cells harbor the virus in X-linked lymphoproliferative disease patients. Blood. 2008;112:672-679.
27. Herbst H, Niedobitek G. Phenotype determination of Epstein-Barr virus-infected cells in tissue sections. Methods Mol Biol. 2001;174:93-102.
28. Niedobitek G, Herbst H. In situ detection of Epstein-Barr virus and phenotype determination of EBV-infected cells. Methods Mol Biol. 2006; 326:115-137.
29. Williams H, Macsween K, McAulay K, et al. Analysis of immune activation and clinical events in acute infectious mononucleosis. J Infect Dis. 2004;190:63-71. (Pubitemid 38858405)
30. Klein U, Tu Y, Stolovitzky GA, et al. Transcriptional analysis of the B cell germinal center reaction. Proc Natl Acad Sci U S A. 2003;100:2639-2644. (Pubitemid 36297551)
31. Rochford R, Hobbs MV, Garnier JL, Cooper NR, Cannon MJ. Plasmacytoid differentiation of Epstein-Barr virus-transformed B cells in vivo is associated with reduced expression of viral latent genes. Proc Natl Acad Sci U S A. 1993;90:352-356. (Pubitemid 23010308)
32. O'Nions J, Allday MJ. Proliferation and differentiation in isogenic populations of peripheral B cells activated by Epstein-Barr virus or T cell-derived mitogens. J Gen Virol. 2004;85:881-895. (Pubitemid 38489554)
33. Ma CS, Hare NJ, Nichols KE, et al. Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells. J Clin Invest. 2005;115: 1049-1059.
34. Ma CS, Pittaluga S, Avery DT, et al. Selective generation of functional somatically mutated IgM+CD27+, but not Ig isotype-switched, memory B cells in X-linked lymphoproliferative disease. J Clin Invest. 2006;116:322-333. (Pubitemid 43228349)
35. Ma CS, Nichols KE, Tangye SG. Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules. Annu Rev Immunol. 2007;25:337-379.
36. Souza TA, Stollar BD, Sullivan JL, Luzuriaga K, Thorley-Lawson DA. Peripheral B cells latently infected with Epstein-Barr virus display molecular hallmarks of classical antigen-selected memory B cells. Proc Natl Acad Sci U S A. 2005;102: 18093-18098. (Pubitemid 41798507)
37. Souza TA, Stollar BD, Sullivan JL, Luzuriaga K, Thorley-Lawson DA. Influence of EBV on the peripheral blood memory B cell compartment. J Immunol. 2007;179:3153-3160.
38. Scheeren FA, Nagasawa M, Weijer K, et al. T cell-independent development and induction of somatic hypermutation in human IgM+IgD+CD27+ B cells. J Exp Med. 2008;205: 2033-2042.
39. Chaganti S, Bell AI, Pastor NB, et al. Epstein-Barr virus infection in vitro can rescue germinal center B cells with inactivated immunoglobulin genes. Blood. 2005;106:4249-4252. (Pubitemid 41775933)
40. Siemer D, Kurth J, Lang S, Lehnerdt G, Stanelle J, Kuppers R. EBV transformation overrides gene expression patterns of B cell differentiation stages. Mol Immunol. 2008;45:3133-3141.
41. Balfour HH Jr, Holman CJ, Hokanson KM, et al. A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis. J Infect Dis. 2005;192:1505-1512.
42. Fafi-Kremer S, Morand P, Brion JP, et al. Longterm shedding of infectious Epstein-Barr virus after infectious mononucleosis. J Infect Dis. 2005; 191:985-989. (Pubitemid 40349816)
43. Flano E, Kim IJ, Woodland DL, Blackman MA. Gamma-herpesvirus latency is preferentially maintained in splenic germinal center and memory B cells. J Exp Med. 2002;196:1363-1372. (Pubitemid 35375555)
44. Willer DO, Speck SH. Long-term latent murine Gammaherpesvirus 68 infection is preferentially found within the surface immunoglobulin D-negative subset of splenic B cells in vivo. J Virol. 2003;77:8310-8321.
45. Simas JP, Bowden RJ, Paige V, Efstathiou S. Four tRNA-like sequences and a serpin homologue encoded by murine gammaherpesvirus 68 are dispensable for lytic replication in vitro and latency in vivo. J Gen Virol. 1998;79:149-153. (Pubitemid 28039313)
46. Niedobitek G, Herbst H, Young LS, et al. Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue. Blood. 1992;79:2520-2526.
47. Araujo I, Foss HD, Hummel M, et al. Frequent expansion of Epstein-Barr virus (EBV) infected cells in germinal centres of tonsils from an area with a high incidence of EBV-associated lymphoma. J Pathol. 1999;187:326-330. (Pubitemid 29064159)
48. Kuppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer. 2005;5:251-262.
49. Traggiai E, Chicha L, Mazzucchelli L, et al. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science. 2004; 304:104-107. (Pubitemid 38451466)
50. Cocco M, Bellan C, Tussiwand R, et al. CD34+ cord blood cell-transplanted Rag2-/- gamma(c)-/- mice as a model for Epstein-Barr virus infection. Am J Pathol. 2008;173:1369-1378.